Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Triamcinolone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,694Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/11/2024 Pfizer Inc
    U.S.A
    		 Pharmacia & Upjohn Company Kalamazoo US R0-CEP 2001-127 - Rev 00 Triamcinolone 5, (9beta,11beta-Epoxy-16alpha,17alpha,21-trihydroxypregna-1,4-diene-3,20-dione) 2002-04-09 Expired TSE 2007-04-09
    28/11/2024 Pfizer Inc
    U.S.A
    		 Pharmacia & Upjohn Company Kalamazoo US R0-CEP 2001-230 - Rev 00 Triamcinolone 3, (21-(acetyloxy)pregna-1,4,9(11)-16-tetraene-3,20-dione) 2002-04-09 Withdrawn by Holder TSE 2006-04-24